Specific tolerance induction and transplantation: A single-day protocol

被引:25
作者
deVriesvanderZwan, A
Besseling, AC
deWaal, LP
Boog, CJP
机构
[1] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT TRANSPLANTAT IMMUNOL,NL-1066 CX AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,CLIN & EXPT IMMUNOL LAB,AMSTERDAM,NETHERLANDS
关键词
D O I
10.1182/blood.V89.7.2596
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone marrow transfusion is a well-established method for induction of mixed hematopoietic chimerism and donor-specific tolerance in animal models. This procedure, however, is inapplicable in clinical transplantation using cadaveric donors due to the interval (1 week to 7 months) between tolerance induction and organ transplantation. For clinical use, it is essential that allografts be placed at the time of bone marrow transfusion. In the present study, we performed skin transplantation within 1 hour after a nonlethal conditioning regimen. Recipient mice were treated with anti-CD3, anti-CD4, low-dose total body irradiation (3 to 6 Gy TBI) and fully mismatched or haploidentical donor bone marrow cells. Stable multilineage chimerism and specific T-cell nonresponsiveness developed. Donor skin grafts were permanently accepted. These results suggest that this single day protocol has clear potential for application in both cadaveric and living-related organ transplantation. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2596 / 2601
页数:6
相关论文
共 22 条
  • [1] Burke GW, 1995, TRANSPLANT P, V27, P3121
  • [2] COLSON YL, 1995, J IMMUNOL, V155, P4179
  • [3] COLSON YL, 1995, TRANSPLANTATION, V60, P971
  • [4] de Vries-van der Zwan A, 1996, Transpl Immunol, V4, P232, DOI 10.1016/S0966-3274(96)80023-2
  • [5] ANTI-CD3 TREATMENT FACILITATES ENGRAFTMENT OF FULL H-2-DISPARATE DONOR BONE-MARROW CELLS AND SUBSEQUENT SKIN ALLOGRAFT TOLERANCE
    DEVRIESVANDERZWAN, A
    BESSELING, AC
    KIEVITS, F
    VANTWUYVER, E
    DEWAAL, LP
    [J]. TRANSPLANTATION, 1994, 58 (05) : 610 - 617
  • [6] ELBADRI NS, 1994, P SOC EXP BIOL MED, V205, P67
  • [7] CYTOKINE-RELATED SYNDROME FOLLOWING INJECTION OF ANTI-CD3 MONOCLONAL-ANTIBODY - FURTHER EVIDENCE FOR TRANSIENT INVIVO T-CELL ACTIVATION
    FERRAN, C
    SHEEHAN, K
    DY, M
    SCHREIBER, R
    MERITE, S
    LANDAIS, P
    NOEL, LH
    GRAU, G
    BLUESTONE, J
    BACH, JF
    CHATENOUD, L
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (03) : 509 - 515
  • [8] BONE-MARROW AUGMENTATION OF DONOR-CELL CHIMERISM IN KIDNEY, LIVER, HEART, AND PANCREAS ISLET TRANSPLANTATION
    FONTES, P
    RAO, AS
    DEMETRIS, AJ
    ZEEVI, A
    TRUCCO, M
    CARROLL, P
    RYBKA, W
    RUDERT, WA
    RICORDI, C
    DODSON, F
    SHAPIRO, R
    TZAKIS, A
    TODO, S
    ABUELMAGD, K
    JORDAN, M
    FUNG, JJ
    STARZL, TE
    [J]. LANCET, 1994, 344 (8916) : 151 - 155
  • [9] HILL RS, 1986, BLOOD, V67, P811
  • [10] MIXED ALLOGENEIC CHIMERISM AND RENAL-ALLOGRAFT TOLERANCE IN CYNOMOLGUS MONKEYS
    KAWAI, T
    COSIMI, AB
    COLVIN, RB
    POWELSON, J
    EASON, J
    KOZLOWSKI, T
    SYKES, M
    MONROY, R
    TANAKA, M
    SACHS, DH
    [J]. TRANSPLANTATION, 1995, 59 (02) : 256 - 262